Sampo May Consider Selling Nordea Stake Within Two Years: DI
(Bloomberg) --
Nordea Bank Abp's largest shareholder, Finnish investment company Sampo Oyj, may consider selling its stake in the bank in the coming years, Swedish daily Dagens Industri reported.
Sampo is testing the water ahead of a potential sale, which could happen within the next two years, according to the report, which cited anonymous sources.
Sampo, which also owns the Sweden-based insurance company If, as well as almost half of Danish insurer Topdanmark A/S, holds 19.9% of Nordea's outstanding shares. That makes it by far the largest shareholder in the bank, ahead of activist investor Cevian Capital, which has built a 4.4% stake since making its first purchases late 2018.
Since Torbjorn Magnusson took over as chief executive officer in January, Sampo has been led by executives with a background in the insurance industry, and a Nordea divestment could be attractive as a way to further increase its focus on that industry. Sampo agreed to buy a majority stake in the U.K. non-life insurer Hastings Group Holdings Plc in August, and said the deal was “a step in the strategy to allocate more capital to property and casualty insurance.”
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.